NERV logo

Minerva Neurosciences (NERV) Accounts Payable

Annual Accounts Payable

$1.81 M
+$835.60 K+86.17%

31 December 2023

NERV Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$553.20 K
-$275.10 K-33.21%

30 September 2024

NERV Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NERV Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+86.2%-60.4%
3 y3 years+81.3%-53.9%
5 y5 years+0.3%-89.6%

NERV Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-2.6%+86.2%-70.2%+85.5%
5 y5 years-22.1%+86.2%-89.6%+85.5%
alltimeall time-22.1%-89.6%+85.5%

Minerva Neurosciences Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$553.20 K(-33.2%)
June 2024
-
$828.30 K(-42.3%)
Mar 2024
-
$1.44 M(-20.5%)
Dec 2023
$1.81 M(+86.2%)
$1.81 M(+29.4%)
Sept 2023
-
$1.40 M(+367.7%)
June 2023
-
$298.30 K(-69.0%)
Mar 2023
-
$961.00 K(-0.9%)
Dec 2022
$969.70 K(-47.7%)
$969.70 K(+82.0%)
Sept 2022
-
$532.90 K(-64.9%)
June 2022
-
$1.52 M(-4.2%)
Mar 2022
-
$1.59 M(-14.4%)
Dec 2021
$1.85 M(+86.1%)
$1.85 M(+54.4%)
Sept 2021
-
$1.20 M(-24.7%)
June 2021
-
$1.59 M(+41.1%)
Mar 2021
-
$1.13 M(+13.5%)
Dec 2020
$995.60 K(-57.0%)
$995.60 K(+41.9%)
Sept 2020
-
$701.60 K(-77.6%)
June 2020
-
$3.14 M(+4.5%)
Mar 2020
-
$3.00 M(+29.6%)
Dec 2019
$2.32 M
$2.32 M(-56.5%)
Sept 2019
-
$5.33 M(+81.2%)
June 2019
-
$2.94 M(-2.8%)
DateAnnualQuarterly
Mar 2019
-
$3.03 M(+68.1%)
Dec 2018
$1.80 M(+25.4%)
$1.80 M(+105.8%)
Sept 2018
-
$874.70 K(-33.2%)
June 2018
-
$1.31 M(-53.6%)
Mar 2018
-
$2.82 M(+96.8%)
Dec 2017
$1.44 M(-2.2%)
$1.44 M(-4.5%)
Sept 2017
-
$1.50 M(+5.0%)
June 2017
-
$1.43 M(-56.3%)
Mar 2017
-
$3.28 M(+123.1%)
Dec 2016
$1.47 M(+7.9%)
$1.47 M(+76.2%)
Sept 2016
-
$833.20 K(-4.9%)
June 2016
-
$876.50 K(-28.4%)
Mar 2016
-
$1.22 M(-10.0%)
Dec 2015
$1.36 M(+112.0%)
$1.36 M(+85.2%)
Sept 2015
-
$734.80 K(+30.2%)
June 2015
-
$564.30 K(-45.5%)
Mar 2015
-
$1.03 M(+61.2%)
Dec 2014
$641.80 K(+22.7%)
$641.80 K(-31.9%)
Sept 2014
-
$942.20 K(-78.2%)
June 2014
-
$4.32 M(+55.1%)
Mar 2014
-
$2.79 M(+433.2%)
Dec 2013
$523.00 K(>+9900.0%)
$523.00 K
Dec 2012
$0.00
-

FAQ

  • What is Minerva Neurosciences annual accounts payable?
  • What is the all time high annual accounts payable for Minerva Neurosciences?
  • What is Minerva Neurosciences annual accounts payable year-on-year change?
  • What is Minerva Neurosciences quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Minerva Neurosciences?
  • What is Minerva Neurosciences quarterly accounts payable year-on-year change?

What is Minerva Neurosciences annual accounts payable?

The current annual accounts payable of NERV is $1.81 M

What is the all time high annual accounts payable for Minerva Neurosciences?

Minerva Neurosciences all-time high annual accounts payable is $2.32 M

What is Minerva Neurosciences annual accounts payable year-on-year change?

Over the past year, NERV annual accounts payable has changed by +$835.60 K (+86.17%)

What is Minerva Neurosciences quarterly accounts payable?

The current quarterly accounts payable of NERV is $553.20 K

What is the all time high quarterly accounts payable for Minerva Neurosciences?

Minerva Neurosciences all-time high quarterly accounts payable is $5.33 M

What is Minerva Neurosciences quarterly accounts payable year-on-year change?

Over the past year, NERV quarterly accounts payable has changed by -$841.90 K (-60.35%)